Profil
Gregory D.
Kunst is currently Chief Executive Officer & Director at Valitor, Inc. since 2025 and Director at Pr3vent, Inc. Former positions include Co-Chief Executive Officer & Director at Aurion Biotech, Inc., Global Marketing Director at Alcon, Inc., and Vice President-Global Marketing at Glaukos Corp.
Education includes an MBA from Vanderbilt University and an undergraduate degree from Brigham Young University.
Aktive Positionen von Gregory Kunst
| Unternehmen | Position | Beginn |
|---|---|---|
Pr3vent, Inc
Pr3vent, Inc Medical/Nursing ServicesHealth Services Provides healthcare technology services | Direktor/Vorstandsmitglied | - |
Valitor, Inc.
Valitor, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops novel methods of modifying therapeutic proteins | Vorstandsvorsitzender | 17.10.2025 |
Ehemalige bekannte Positionen von Gregory Kunst
| Unternehmen | Position | Ende |
|---|---|---|
| GLAUKOS CORPORATION | Vertrieb & Marketing | - |
Aurion Biotech, Inc.
Aurion Biotech, Inc. BiotechnologyHealth Technology Develops advanced cell therapies to treat eye diseases | Vorstandsvorsitzender | - |
Ausbildung von Gregory Kunst
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Glaukos Corp.
Glaukos Corp. Medical SpecialtiesHealth Technology Operates as an ophthalmic medical device company | Health Technology |
Vanderbilt University
Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brigham Young University
Brigham Young University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Valitor, Inc.
Valitor, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops novel methods of modifying therapeutic proteins | Health Technology |
Pr3vent, Inc
Pr3vent, Inc Medical/Nursing ServicesHealth Services Provides healthcare technology services | Health Services |
Aurion Biotech, Inc.
Aurion Biotech, Inc. BiotechnologyHealth Technology Develops advanced cell therapies to treat eye diseases | Health Technology |
















